Nemluvio 30 MG
Ended Awarded
- Contract number
- 36C24526N0173
- Awardee
-
Galderma Laboratories, L.P. UEI MNX4XY6QXEL3
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $31,800
Award facts
- Contract value 100% obligated
- $31,800.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Carrollton, TX 75010, USA
Award details come from SAM.gov/FPDS.
About this award
Galderma Laboratories, L.P., a foreign-owned pharmaceutical manufacturer based in Dallas, Texas, received a $31.8K delivery order from Veterans Integrated Service Network 5 (VISN 5) for NEMLUVIO 30 mg. The contract, awarded on December 2, 2025, with a completion date of December 3, 2025, represents a firm fixed-price arrangement with no set-aside designation. This delivery order falls under the broader Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) managed by the General Services Administration, with the Department of Veterans Affairs serving as the funding agency. The place of performance is Carrollton, Texas.
This award reflects Galderma Laboratories' established role as a specialized supplier of injectable pharmaceutical products to the VA healthcare system. The company has demonstrated a consistent track record delivering NEMOLIZUMAB and NEMLUVIO medications across multiple VISN regions, with recent contract values ranging from approximately $3K to $25K. The short completion timeline suggests this is a time-sensitive delivery for VA patient care needs, consistent with the company's focused approach to supporting federal healthcare networks with specialized injectable medications.
Quick answers
Who was awarded contract 36C24526N0173?
36C24526N0173 was awarded to Galderma Laboratories, L.P. by Veterans Integrated Service Network 5 (Veterans Health Administration) on December 2, 2025.
How much is contract 36C24526N0173 worth?
The government has obligated $31,800 on 36C24526N0173.
Is contract 36C24526N0173 an order under another contract?
Yes. 36C24526N0173 is a delivery order under V797D70255, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24526N0173 competed?
The extent of competition for 36C24526N0173 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award